Related Experiment Videos
A loading-dose infusion scheme for intravenous tocolysis with ritodrine: a pilot study
C A Holleboom1, J M Merkus, L W van Elferen
1Department of Obstetrics and Gynecology, Maria Hospital Tilburg, The Netherlands.
Summary
A new intravenous ritodrine infusion scheme for preterm labor uses a high loading dose, then reduces the rate to maintain therapeutic levels. This approach accounts for ritodrine
Area of Science:
- Pharmacology
- Obstetrics and Gynecology
Background:
- Preterm labor is a significant concern in obstetrics.
- Intravenous ritodrine is a common tocolytic agent used to manage preterm labor.
- Optimizing ritodrine infusion schemes is crucial for effective and safe treatment.
Purpose of the Study:
- To evaluate a loading-dose infusion scheme for intravenous ritodrine therapy in patients with preterm labor.
- To determine the pharmacokinetic profile of ritodrine during the dynamic loading phase.
- To inform the development of improved ritodrine infusion protocols.
Main Methods:
- Twelve patients with preterm labor received intravenous ritodrine therapy.
- A high initial infusion rate was administered, followed by a reduced maintenance rate upon achieving tocolysis.
- Plasma samples were collected at the point of tocolysis and during the steady state for ritodrine concentration analysis.
Main Results:
- The dynamic loading phase of ritodrine exhibited a half-life of approximately 1 hour.
- This observed half-life was attributed to the cumulation of ritodrine in the central compartment, termed 'cumulation t1/2'.
- Measured plasma concentrations were compared with expected and calculated values.
Conclusions:
- The identified cumulation half-life (t1/2) of 1 hour is a critical factor for designing effective ritodrine loading-dose infusion schemes.
- This pharmacokinetic data should be incorporated into future protocols for intravenous ritodrine therapy in preterm labor.
- Optimized infusion schemes can potentially improve therapeutic outcomes and patient management.